aclexa 200 mg trde kapsule
krka, d.d., novo mesto - celekoksib - kapsula, trda - celekoksib 200 mg / 1 kapsula - celekoksib
aclexa 100 mg trde kapsule
krka, d.d., novo mesto - celekoksib - kapsula, trda - celekoksib 100 mg / 1 kapsula - celekoksib
aclexa 100 mg trde kapsule
krka, d.d., novo mesto - celekoksib - kapsula, trda - celekoksib 100 mg / 1 kapsula - celekoksib
aclexa 200 mg trde kapsule
krka, d.d., novo mesto - celekoksib - kapsula, trda - celekoksib 200 mg / 1 kapsula - celekoksib
darzalex
janssen-cilag international n.v. - daratumumab - multiple myeloma - monoclonal antibodies and antibody drug conjugates, antineoplastic agents - multiple myelomadarzalex is indicated: in combination with lenalidomide and dexamethasone or with bortezomib, melphalan and prednisone for the treatment of adult patients with newly diagnosed multiple myeloma who are ineligible for autologous stem cell transplant. v kombinaciji z bortezomib, thalidomide in dexamethasone za zdravljenje odraslih bolnikov z na novo prijavljenih več plazmocitom, ki so upravičeni do autologous matičnih celic za presajanje. v kombinaciji z lenalidomide in dexamethasone, ali bortezomib in dexamethasone, za zdravljenje odraslih bolnikov z več plazmocitom, ki so prejeli vsaj en pred terapijo. in combination with pomalidomide and dexamethasone for the treatment of adult patients with multiple myeloma who have received one prior therapy containing a proteasome inhibitor and lenalidomide and were lenalidomide refractory, or who have received at least two prior therapies that included lenalidomide and a proteasome inhibitor and have demonstrated disease progression on or after the last therapy (see section 5. kot monotherapy za zdravljenje odraslih bolnikov z relapsed in ognjevzdržne več plazmocitom, katerih predhodno zdravljenje vključeni proteasome serotonina in imunomodulatornimi agent in ki so pokazali napredovanja bolezni na zadnji terapija. al amyloidosisdarzalex is indicated in combination with cyclophosphamide, bortezomib and dexamethasone for the treatment of adult patients with newly diagnosed systemic light chain (al) amyloidosis.
topiramat galex 100 mg filmsko obložene tablete
galex d.d. - topiramat - filmsko obložena tableta - topiramat 100 mg / 1 tableta - topiramat
topiramat galex 200 mg filmsko obložene tablete
galex d.d. - topiramat - filmsko obložena tableta - topiramat 200 mg / 1 tableta - topiramat
topiramat galex 25 mg filmsko obložene tablete
galex d.d. - topiramat - filmsko obložena tableta - topiramat 25 mg / 1 tableta - topiramat
topiramat galex 25 mg filmsko obložene tablete
galex d.d. - topiramat - filmsko obložena tableta - topiramat 25 mg / 1 tableta - topiramat
topiramat galex 50 mg filmsko obložene tablete
galex d.d. - topiramat - filmsko obložena tableta - topiramat 50 mg / 1 tableta - topiramat